The use of recombinant human epidermal growth factor (rhEGF) in a gentleman with drug-induced Steven Johnson syndrome.
A case of drug-induced Steven Johnson syndrome in a gentleman is reported. Its course of treatment with rhEGF was compared to conventional treatment in historical control.
Tsang
Man Wo
MW
Tsang
Ka Yan
KY
Wong
Wan Keung R
WK
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003680:Deglutition Disorders / Q000209:etiology; D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D005440:Fluid Therapy; D006073:Gout / Q000188:drug therapy; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D008297:Male; D008528:Mefenamic Acid / Q000009:adverse effects / Q000627:therapeutic use; D009824:Ointments; D020795:Photophobia / Q000209:etiology; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012189:Retrospective Studies; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced / Q000188:drug therapy* / Q000453:epidemiology
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D009824:Ointments; D011994:Recombinant Proteins; D008528:Mefenamic Acid; D004815:Epidermal Growth Factor